Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Transdiagnostic Sleep and Circadian Treatment to Improve Community SMI Outcomes

NCT02469233 is registered in ClinicalTrials.gov with University of California, Berkeley as lead sponsor.

NCT NCT02469233
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02469233 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Transdiagnostic Sleep and Circadian Treatment to Improve Community SMI Outcomes
Lead sponsor
University of California, Berkeley
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2015
Completion date
April 17, 2019
Enrollment
121 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mental disorders